Breast cancer is divided into three subgroups based on the presence or absence of estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2) overexpression [3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.